NYSE:LCI - Lannett Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$9.55 -0.27 (-2.75 %)
(As of 02/20/2019 08:52 AM ET)
Previous Close$9.82
Today's Range$9.50 - $10.4527
52-Week Range$3.33 - $17.58
Volume2.27 million shs
Average Volume1.66 million shs
Market Capitalization$375.22 million
P/E Ratio3.08
Dividend YieldN/A
Beta2.48
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, suspension, soft gel, and injectable dosages. It also provides its products for various medical indications comprising cholesterol, muscle spasm, pain management, irritable bowel, antipsychosis, gastrointestinal, cardiovascular, thyroid deficiency, central nervous system, urinary, migraine, bronchospasms, and gallstone. In addition, the company manufactures active pharmaceutical ingredients. It markets its products under the Lipitor, Lioresal, Bentyl, Prolixin, MiraLAX, Imdur, Levoxyl/Synthroid, Concerta, Toprol-XL, Prilosec, Ditropan, Protonix, Imitrex, Brethine, and Actigall brands to generic pharmaceutical and private label distributors, drug wholesalers, chain drug retailers, mail-order pharmacies, other pharmaceutical manufacturers, managed care and health maintenance organizations, hospital buying groups, and governmental entities. The company has supply and development agreements with Jerome Stevens Pharmaceuticals, Summit Bioscience LLC, HEC Pharm Group, Andor Pharmaceuticals LLC, Dexcel Pharma, and Aralez Pharmaceuticals. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.

Receive LCI News and Ratings via Email

Sign-up to receive the latest news and ratings for LCI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP51601210
Phone215-333-9000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$684.56 million
Cash Flow$4.4419 per share
Book Value$8.31 per share

Profitability

Net Income$28.69 million

Miscellaneous

Employees1,251
Market Cap$375.22 million
OptionableOptionable

Lannett (NYSE:LCI) Frequently Asked Questions

What is Lannett's stock symbol?

Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."

How were Lannett's earnings last quarter?

Lannett Company, Inc. (NYSE:LCI) released its quarterly earnings results on Wednesday, February, 6th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.68 by $0.18. The business earned $193.70 million during the quarter, compared to analysts' expectations of $162.51 million. Lannett had a positive return on equity of 22.88% and a negative net margin of 39.44%. The firm's revenue for the quarter was up 5.1% compared to the same quarter last year. During the same period in the previous year, the business posted $1.06 earnings per share. View Lannett's Earnings History.

When is Lannett's next earnings date?

Lannett is scheduled to release their next quarterly earnings announcement on Monday, May 6th 2019. View Earnings Estimates for Lannett.

What guidance has Lannett issued on next quarter's earnings?

Lannett issued an update on its FY 2019 earnings guidance on Wednesday, February, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $615-635 million, compared to the consensus revenue estimate of $598.79 million.

What price target have analysts set for LCI?

5 analysts have issued twelve-month price objectives for Lannett's shares. Their predictions range from $8.00 to $43.00. On average, they expect Lannett's share price to reach $26.1667 in the next year. This suggests a possible upside of 174.0% from the stock's current price. View Analyst Price Targets for Lannett.

What is the consensus analysts' recommendation for Lannett?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lannett in the last year. There are currently 5 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Lannett.

Has Lannett been receiving favorable news coverage?

News stories about LCI stock have trended somewhat positive on Wednesday, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Lannett earned a daily sentiment score of 1.4 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Who are some of Lannett's key competitors?

Who are Lannett's key executives?

Lannett's management team includes the folowing people:
  • Mr. Timothy C. Crew, CEO & Director (Age 58)
  • Mr. Martin P. Galvan, VP of Fin. & CFO (Age 67)
  • Mr. Samuel H. Israel, Gen. Counsel & Chief Legal Officer (Age 57)
  • Mr. John M. Abt, VP & Chief Quality Operations Officer (Age 54)
  • Mr. John Kozlowski, Chief of Staff & Strategy Officer (Age 47)

Who are Lannett's major shareholders?

Lannett's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Telemus Capital LLC (20.07%), BlackRock Inc. (12.14%), Canada Pension Plan Investment Board (2.81%), Dimensional Fund Advisors LP (2.05%), Bank of New York Mellon Corp (1.57%) and Alambic Investment Management L.P. (1.07%). Company insiders that own Lannett stock include Albert Paonessa III, Arthur P Bedrosian, David Farber, Kevin Smith, Patrick G Lepore and Timothy C Crew. View Institutional Ownership Trends for Lannett.

Which institutional investors are selling Lannett stock?

LCI stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Telemus Capital LLC, CLARET ASSET MANAGEMENT Corp, Northern Trust Corp, KBC Group NV, Bank of New York Mellon Corp, Jane Street Group LLC and SG Americas Securities LLC. View Insider Buying and Selling for Lannett.

Which institutional investors are buying Lannett stock?

LCI stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Canada Pension Plan Investment Board, Alambic Investment Management L.P., Two Sigma Investments LP, Prudential Financial Inc., Two Sigma Advisers LP, Martingale Asset Management L P and Municipal Employees Retirement System of Michigan. Company insiders that have bought Lannett stock in the last two years include Albert Paonessa III, Patrick G Lepore and Timothy C Crew. View Insider Buying and Selling for Lannett.

How do I buy shares of Lannett?

Shares of LCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Lannett's stock price today?

One share of LCI stock can currently be purchased for approximately $9.55.

How big of a company is Lannett?

Lannett has a market capitalization of $375.22 million and generates $684.56 million in revenue each year. The company earns $28.69 million in net income (profit) each year or $3.10 on an earnings per share basis. Lannett employs 1,251 workers across the globe.

What is Lannett's official website?

The official website for Lannett is http://www.lannett.com.

How can I contact Lannett?

Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The company can be reached via phone at 215-333-9000.


MarketBeat Community Rating for Lannett (NYSE LCI)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  408 (Vote Outperform)
Underperform Votes:  321 (Vote Underperform)
Total Votes:  729
MarketBeat's community ratings are surveys of what our community members think about Lannett and other stocks. Vote "Outperform" if you believe LCI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LCI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel